OAR 855-045-0210
Registration

(1)

A non-resident drug outlet that distributes a non-patient specific compounded drug into Oregon must be registered with the FDA as a 503B Outsourcing Facility and must register with the Board as a manufacturer drug outlet.
(2) A resident drug outlet that distributes a non-patient specific human compounded drug within or outside of Oregon must register with the FDA as a 503B Outsourcing Facility and must register with the Board as a manufacturer drug outlet.

Source: Rule 855-045-0210 — Registration, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-045-0210.

Last Updated

Jun. 8, 2021

Rule 855-045-0210’s source at or​.us